Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). 

CEO
Daniel R. Passeri
CEODaniel R. Passeri
Employees
41
Employees41
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
41
Employees41

CUE Key Statistics

Market cap
56.29M
Market cap56.29M
Price-Earnings ratio
-1.35
Price-Earnings ratio-1.35
Dividend yield
Dividend yield
Average volume
136.26K
Average volume136.26K
High today
$0.7584
High today$0.7584
Low today
$0.71
Low today$0.71
Open price
$0.75
Open price$0.75
Volume
84.89K
Volume84.89K
52 Week high
$1.99
52 Week high$1.99
52 Week low
$0.45
52 Week low$0.45

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.